ARCHIVES

FDA Faces Severe Regulatory, Scientific Needs, Report Finds.

This article is from The Cancer Letter archive.

Vol. 34 No. 04 | February 1, 2008

Download PDF Visit The Full Archive

Related Articles

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

Rosenberg: Immunotherapy May Have Broad Potential

June 24, 2005

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006

FDA Delays NDA On BCNU, But New Drug Seminar Still Scheduled

November 28, 1975

Cancer, AIDS Drug Screening Contracts Ok’d For Recompetition

February 28, 1992